Neuromuscular Disease Center

The Neuromuscular Disease Center provides diagnosis and comprehensive treatment of Neuromuscular diseases in both adults and children. Within the Neuromuscular Disease Center, there are several specialty clinics that include the ALS Clinic, the Muscular Dystrophy Association (MDA) Clinic / Neuromuscular Clinic, Neuropathy Clinic, and the Periodic Paralysis, Myotonia, and the Episodic Ataxia Clinic. The Neuromuscular labs include the URMC EMG Lab and the neuropathology lab.

Neuromuscular diseases involve conditions of the nerves and muscles, including:

  • Acquired or hereditary peripheral neuropathies
  • Muscular dystrophies such as:
    • Duchenne dystrophy
    • Facioscapulohumeral muscular dystrophy (FSH)
    • Limb-girdle muscular dystrophy
    • Myotonic dystrophy
  • Inclusion body myositis (IBM)
  • Inflammatory myopathy and other myopathies
  • Myasthenia gravis
  • Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig’s disease)
  • Ataxias
  • Periodic paralysis
  • Non-dystrophic myotonias
  • Neuromuscular disorders

Neuromuscular disease diagnostic procedures include:

Our Providers

Neuromuscular Disease Center Faculty
Emma Ciafaloni, M.D.
Robert C. Griggs, M.D.
Chad Heatwole, M.D.
David Herrmann, M.D.
Eric Logigian, M.D.
Richard Moxley III, M.D.
Shreedevi Pandya, R.P.T., M.S.
Araya Puwanant, MD
Michael Stanton, M.D.
Jeffrey Statland, MD
Al-Rabi Tawil, M.D.
Charles Thornton, M.D.
Paul Twydell, D.O.

Neuromuscular Disease Unit

Within the Neuromuscular Disease Center, there are several specialty clinics:

Research

Research in the Neuromuscular Disease Center includes therapeutic trials, pathophysiology, animal and cellular models of disease, molecular genetic alterations, pathomechanisms and identification of new treatments of neuromuscular diseases. Our goals are to understand the molecular pathology and its relationship to the metabolic alterations that cause the manifestations of each disease and to develop more rational approaches to their treatment.

Scope of Research: Therapeutic Trials, Pathophysiology, Animal and Cellular Models of Disease, Molecular Genetic Alterations, Pathomechanisms and Identification of New Treatments of Neuromuscular Diseases

Goals are to understand the molecular pathology and its relationship to the metabolic alterations that cause the manifestations of each disease and to develop more rational approaches to their treatment.

  • Therapeutic trials in Myotonic Dystrophy, Myotonic Dystrophy (Type 1 and Type 2), Facioscapulohumeral Dystrophy, Inclusion Body Myositis, Myasthenia Gravis, Duchenne Dystrophy, Limb Girdle Muscular Dystrophies, Non-Dystrophic Myotonic disorders, Periodic Paralysis, Charcot-Marie-Tooth disease and Amyotrophic Lateral Sclerosis.
  • Clinical pathophysiology of: a) myotonia; b) muscle wasting in Myotonic Dystrophy (Types 1 and 2) and Facioscapulohumeral Muscular dystrophy; c) corticosteroid beneficial and toxic effects in Duchenne dystrophy; d) cognitive-personality changes and sleep alterations in Myotonic Dystrophy (Types 1 and 2); e) muscle pain in Myotonic Dystrophy (Types 1 and 2) and Facioscapulohumeral muscular Dystrophy; f) Small Fiber Neuropathies; and g) Charcot-Marie-Tooth disease.
  • Animal and Cellular Models of: a) Myotonic dystrophy Type 1; b) oculopharyngeal muscular dystrophy; and c) in development is animal model of myotonic dystrophy Type 2.
  • Pathomechanisms and Identification of treatments for: a) myotonic dystrophy type 1 using cell culture systems to screen for molecular alterations that disappear with specific drugs in the media; b) myotonic dystrophy type 1 and Facioscapulohumeral muscular dystrophy using gene chip studies of gene expression in muscle biopsy specimens; and c) myotonic dystrophy type 1 and oculopharyngeal muscular dystrophy using mouse models of these disorders to examine alterations in specific target tissues (the characteristic muscles involved; brain; heart; lens).
  • Electrodiagnostic and histologic features and treatment outcome of various neuropathies, particularly Charcot-Marie-Tooth disease, selected small fiber polyneuropathies, acute and chronic inflammatory demyelinative polyneuropathy, and other hereditary polyneuropathies.
  • Our Locations

    Strong Memorial Hospital
    601 Elmwood Avenue
    Rochester, NY 14642
    Directions to Strong Memorial Hospital

    EMG Lab
    919 Westfall Road
    Building C, Suite 220
    Rochester, NY 14618
    Directions to Westfall Road Clinic

Additional Resources

 

Eric L. Logigian, M.D.

Eric L. Logigian, M.D.
Unit Chief

Jared's Story

Jared Wright

A young boy battles muscular dystrophy with the help of some of the world's leading experts.

Contact Us

To contact us directly please call 585-275-2559.

To schedule EMG and nerve conduction studies at Strong Memorial Hospital or Highland Hospital, call 585-275-4568.

Schedule an Appointment

To schedule an appointment or to speak with one of our neurologists, please call 585-275-1200. If you must cancel your appointment, please do so at least 24 hours in advance.

The Department of Neurology participates with Blue Choice, MVP Healthcare, Medicare, Medicaid, and Blue Cross Blue Shield of Rochester health plans.

Co-payments are collected at time of service. We accept cash or check only for all applicable co-payments and personal balances due at the time of service.